Tuesday, January 3, 2017

BRIEF-Cellectis submits IND application for UCART123

* Cellectis submits IND application for UCART123, an

allogeneic gene edited car t-cell product candidate, in AML and

BPDCN

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)